influenza vaccine (IMP-321) (Immutep)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinfluenza vaccine (IMP-321) (Immutep)
Drug Alias Nameinfluenza virus vaccine (Immutep)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmutep SAS
China Registration ClassN/A

Develop Information

Active CompaniesImmutep SAS
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A